Brain Advance Access published online on September 6, 2006
Brain, doi:10.1093/brain/awl223
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Rehabilitation Medicine, VU University Medical Center, Amsterdam, The Netherlands; EMGO Institute, VU University Medical Center, Amsterdam, The Netherlands
* To whom correspondence should be addressed. To select the most useful evaluative outcome measures for early multiple sclerosis, we included 156 recently diagnosed patients in a 3-year follow-up study, and assessed them on 23 outcome measures in the domains of disease-specific outcomes, physical functioning, mental health, social functioning and general health. A global rating scale (GRS) and the Expanded Disability Status Scale (EDSS) were used as external criteria to determine the minimally important change (MIC) for each outcome measure. Subsequently, we determined whether the outcome measures could detect their MIC reliably. From these, per domain the outcome measure that was found to be most sensitive to changes (responsive) was identified. At group level, 11 outcomes of the domains of physical functioning, mental health, social functioning and general health could reliably detect the MIC. Of these 11, the most responsive measures per domain were the Medical Outcome Study 36 Short Form sub-scale physical functioning (SF36pf), the Disability and Impact Profile (DIP) sub-scale psychological, the Rehabilitation Activities Profile sub-scale occupation (RAPocc) and the SF36 sub-scale health, respectively. Overall, the most responsive measures were the SF36pf and the RAPocc. In individual patients, none of the measures could reliably detect the MIC. In sum, in the early stages of multiple sclerosis the most useful evaluative outcome measures for research are the SF36pf (physical functioning) and the RAPocc (social functioning).
Received February 10, 2006
Revised July 21, 2006
Accepted July 25, 2006
Article
The usefulness of evaluative outcome measures in patients with multiple sclerosis
V. de Groot 1 *, H. Beckerman 1, B. M. J. Uitdehaag 2, H. C. W. de Vet 3, G. J. Lankhorst 1, C. H. Polman 4, and L. M. Bouter 3
2 Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands; Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
3 EMGO Institute, VU University Medical Center, Amsterdam, The Netherlands
4 Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
V. de Groot, E-mail: v.degroot{at}vumc.nl
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C Heesen, J Bohm, C Reich, J Kasper, M Goebel, and S. Gold Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable Multiple Sclerosis, August 1, 2008; 14(7): 988 - 991. [Abstract] [PDF] |
||||
![]() |
J. Paltamaa, T. Sarasoja, E. Leskinen, J. Wikstrom, and E. Malkia Measuring Deterioration in International Classification of Functioning Domains of People With Multiple Sclerosis Who Are Ambulatory Physical Therapy, February 1, 2008; 88(2): 176 - 190. [Abstract] [Full Text] [PDF] |
||||

